Jobs
View more job listings or post a job
Alturas Analytics Scientist 1
University of California, Davis TOXICOLOGY ANALYTICAL CHEMIST (STAFF RESEARCH ASSOCIATE 3)
University of California, Davis CALIFORNIA ANIMAL HEALTH AND FOOD SAFETY LABORATORY - TOXICOLOGY LAB RESEARCH SUPERVISOR/GROUP LEADER
Eli Lilly and Company R-39973 Scientific Director ADME - Novel Modalities (Open)
FibroGen Director DMPK
Applied BioMath Technical Marketing Specialist
Horizon Therapeutics Director, Bioanalytical Sciences
Exelixis Principal Scientist - DMPK
Exelixis Senior Principal Scientist - DMPK
Exelixis Principal Clinical DMPK Scientist
Post a job
Symposium

[Free Online] The Science and Stories of Promising Biotech Startups


Speakers: Ritu Lal, Gen1E Lifesciences; Shilpa Sambashivan, Nura; Stefan Ryser, Trellis Bio; Keting Chu, Bluejay; Annahita Keravala, Genascence; Shelley Force Aldred, Rondo Therapeutics; Donald McCarthy, Samsara BioCapital
Organizers: Toby Freedman (Synapsis Search); Sarah Bodary (AbCellera); Donald McCarthy (Samsara BioCapital); Shichang Miao (PBSS)
Date: 2023-08-17
Time: 8:30-13:30 Pacific Time
Registration fee: 0
Location: Online via Zoom
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2023-08-16  (it will close sooner if the seating cap is reached)

About the Topic

This symposium series aims to provide a platform for promising biotech startup companies to highlight their science and share their stories in building a fledgling business.

Pacific Time

Eastern Time

Topic

Presenter

8:30 - 8:40 am

11:30 -11:40 am

Welcome Remarks

Shichang Miao, PBSS

8:40 - 9:15 am

11:40 am -12:15 pm

Clinical-Stage Company in Phase 2 with a Multi-Target AI Platform Accelerating Therapies for Inflammatory and Rare Diseases

Ritu Lal, M.S, PhD, CEO, Gen1e Lifesciences Inc. 

9:15 -9:50 am

12:15 - 12:50 pm

Discovery and Development of Neuroprotective Therapies for the Treatment of Neurological Diseases

Shilpa Sambashivan, PhD, CSO, Nura Bio Inc.

9:50 -10:25 am

12:50 - 1:25 pm

Clinical Proof-of-Concept in a Difficult-to-Treat Infection, human mAb TRL1068 Overcomes Antibiotic Resistance Due to Bacterial Biofilm

Stefan Ryser, PhD, President & CEO, Trellis Bioscience, Inc.

10:25 -11:00 am

1:25 - 2:00 pm

Development of Functional Cure for Chronic HBV Infection

Keting Chu, MD, PHD, CEO & Founder, Bluejay Therapeutics, Inc.

11:00 -11:10 am

2:00 - 2:10 pm

Break Time

  

11:10 - 11:45 pm

2: 10 – 2:45 pm

AAV-Mediated Gene Therapy for Osteoarthritis

Annahita Kervala, PhD, CSO, Genascence

11:45 am- 12:20 pm

2:45 – 3:20 pm

Tackling Solid Tumors with Next-Generation Bispecific Antibodies

Shelley Force Aldred, PhD, CEO & Co-founder, Rondo Therapeutics

12: 20 – 12:55 pm

3:20 – 3:55 pm

Raising capital in today's environment

Donald McCarthy, PhD, VP, Samsara BioCapital

12:55 – 1:30 pm

3:55 – 4:30 pm

Panel Discussion

All Speakers

The Zoom link will be sent one day before the symposium.

Other Events of PBSS-San Francisco Bay:

2023-10-06, [In-Person] Human PK and Dose Prediction for Small Molecules
2023-11-07, [Free Online] The Science and Stories of Promising Biotech Startups
2023-11-13, [In-Person] Clinical Pharmacology Across the Drug Development Continuum: Key Clinical Studies, Modeling & Simulation to Support Drug Approval and Labeling
2023-12-06, [Free Online] Artificial Intelligence and Machine Learning to Drive Therapeutic Drug Discovery & Development
2024-01-19, [In-Person] ADME/DMPK Studies for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices
©Pharmaceutical & BioScience Society, International; Last Modified: 10/1/2023; Admin Logon
 Ads (in random order)
Submit a Text Ad
($250 for 2 months)
Jie Du Center at the University of the Pacific Interested in creating a business in Biotech? Learn how to transition from thinking like a scientist to thinking like an entrepreneur.
Alturas Analytics, Inc. Expert GLP & non-GLP LC-MS/MS, GC-MS/MS bioanalytical & PK/TK analysis services of small & large molecules in any matrix. Discovery through phase IV.
ICON Innovation Workshop in SF Bay Area: Bringing the trial to the patient: Are you driving true patient centricity? Oct 19, Crowne Plaza Foster
Viva Biotech Join Viva Reception if you have a need in MedChem, SBDD, FBDD, CryoEM, ASMS, SPR, HDX, CADD, Bioassay, CMC, Ab, https://www.bagevent.com/event/8673557
BioTether Sciences Bioanalytical CRO, focused on PK, Biomarkers, and Immunogenicity. Custom Assay development, validation and testing. Advanced cell engineering.
Submit a Text Ad